 |
|
On July 21-22, JDRF co-hosted a workshop with the FDA and the National Institutes of Health (NIH) that focused on the state of the art in the research and development of an artificial pancreas. The two-day workshop brought together some of the world's top scientists, regulators, industry representatives, and others with a connection to type 1 diabetes to discuss the progress and remaining challenges in the development of closed-loop systems that will automatically regulate blood sugar in people with diabetes.
The sessions dramatically highlighted advances that have been made since the previous conference in December 2005 in tying together continuous glucose monitors and insulin pumps with sophisticated algorithms to replicate the function of a human pancreas, including ongoing human clinical trials, the development of complex algorithms that ensure these next generation devices will be both safe and effective, and the creation of an in silico model of type 1 diabetes in humans, that can speed clinical trial testing of proposed control algorithms.
Video presentations by the scientists are linked below. A conference summary report is now available here.
Day 1: Introductory Remarks
|
|
State of the Art: Designs and results from the Latest Closed Loop Studies, Part 1
|
State of the Art: Designs and results from the Latest Closed Loop Studies, Part 2
|
|
State of the Art: Designs and results from the Latest Closed Loop Studies, Part 3
|
Defining Success and Failure: Appropriate Measures, Part 1
|
|
Defining Success and Failure: Appropriate Measures, Part 2
|
Algorithms: State of the Art and Future Directions, Part 1
|
|
Algorithms: State of the Art and Future Directions, Part 2
|
Engineering and Patient Considerations When Building a Closed Loop System
|
|
|
Day 2: Welcome and First Day Impressions
- Judith Fradkin, M.D., Director, Division of Diabetes, Endocrinology and Metabolic Diseases, NIDDK, NIH
From Automated Insulin Delivery to an Artificial Pancreas: How We Get There, Part 1
 |
|
From Automated Insulin Delivery to an Artificial Pancreas: How We Get There, Part 2
|
Beyond Insulin Dependent Diabetes, Part 1
 |
|
Beyond Insulin Dependent Diabetes, Part 2
|
Beyond Insulin Dependent Diabetes, Part 3
 |
|
|
Wrap Up
- Hylton V. Joffe, M.D., M.M.Sc., Center for Drug Evaluation and Research, Food and Drug Administration
Disclaimer |
|
|
|
WE Need YOUR HELP! |
|
JDRF is working with health plans to provide coverage for CGMs, but we need your help! Plans need to hear directly from their beneficiaries about this revolutionary technology. The first step is to tell us your health insurance provider.
|
|
Need Answers? |
|
JDRF Volunteers are available to answer your questions about Continuous Glucose Monitors, the Artificial Pancreas and much more.
|
|
